Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Rhea-AI Summary
Tango Therapeutics (NASDAQ: TNGX) will report third quarter 2025 financial results on Tuesday, November 4, 2025 at 9:00 AM ET, to be released before the U.S. market open.
The company said it does not intend to hold a conference call with investors or analysts following the release.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TNGX gained 0.51%, reflecting a mild positive market reaction. This price movement added approximately $5M to the company's valuation, bringing the market cap to $1.05B at that time.
Data tracked by StockTitan Argus on the day of publication.
BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report third quarter 2025 financial results on November 4, 2025 at 9:00am ET, before the open of the U.S. financial markets. The company does not intend to hold a conference call.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
FAQ
When will Tango Therapeutics (TNGX) report Q3 2025 results?
Will Tango Therapeutics (TNGX) host a conference call for the November 4, 2025 release?
How can investors access Tango Therapeutics (TNGX) Q3 2025 results without a conference call?
What time will the Tango Therapeutics (TNGX) Q3 2025 results be released relative to market hours?
Will Tango Therapeutics (TNGX) provide supplemental materials with the November 4, 2025 release?
